Inhaled Nitric Oxide Market Size, Share, Growth Analysis, By Product type(Gas and Delivery System), By Application(Neonatal Respiratory Treatment, Asthma & COPD, Acute Respiratory Distress Syndrome and Malaria Treatment), By End User(Near-term & Pre-term Infants PPHN, Children & Adult ARDS, and Other Diseases), By Region - Industry Forecast 2024-2031

Inhaled Nitric Oxide market size was valued at USD 951.72 million in 2022 and is poised to grow from USD 1027 million in 2023 to USD 1755 million by 2031, at a CAGR of 7.95% in the forecast period (2024-2031).

A crucial chemical for maintaining multiorgan survival and vascular homeostasis is nitric oxide. Its antibacterial qualities, respiratory issues, and cardio-cerebrovascular benefits are all beneficial. Inhaled nitric oxide improves ventilation-perfusion matching and arterial oxygenation by expanding the circulating pulmonary arteries, which increases blood flow to the ventilated areas of the lungs. Supplementing with nitric oxide is a common practice among athletes and fitness enthusiasts. By improving blood flow, oxygen delivery, and muscle nutrient absorption, it improves exercise performance. The primary focus of the major industry actors is the pipeline connections that facilitate the transport of nitrogen, argon, hydrogen, carbon monoxide, and oxygen. The major actors in many end-user industries, such as the pharmaceutical and healthcare sectors, watch over the distribution process.

The increase in end-users around the world is anticipated to propel the inhaled nitric oxide market worldwide. The market for inhaled nitric oxide is expected to rise due to several factors, including rising awareness and acceptance of nitric oxide's use in the healthcare sector, rising rates of cardiovascular and respiratory disorders, technical developments, and research and clinical studies. The market is expected to grow as more medical professionals become aware of the benefits of inhaled nitric oxide and its usage rises. The need for inhaled nitric oxide will rise due to the increasing number of respiratory and cardiovascular diseases, as it will aid in therapy.